Profiel
Herbert Raymond Henney worked as a Senior Director-Medical Affairs at Savient Pharmaceuticals, Inc. and as a Vice President-Clinical & Regulatory Affairs at W World Corp.
He also worked at Acorda Therapeutics, Inc. as a Vice President-Clinical Development from 2011 to 2014.
Henney holds a doctorate degree from the Medical University of South Carolina and an undergraduate degree from Temple University (Pennsylvania).
Eerdere bekende functies van Herbert Raymond Henney
Bedrijven | Functie | Einde |
---|---|---|
ACORDA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2014 |
SAVIENT PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | - |
W WORL | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Herbert Raymond Henney
Temple University (Pennsylvania) | Undergraduate Degree |
Medical University of South Carolina | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ACORDA THERAPEUTICS, INC. | Health Technology |
W WORL | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |